Publications by authors named "Karen Gelmon"

100Publications

Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars.

Drugs 2020 Oct 6. Epub 2020 Oct 6.

Department of Medical Oncology, British Columbia Cancer, 600 W. 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-020-01411-yDOI Listing
October 2020

Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy.

Breast Cancer Res Treat 2020 Nov 20;184(1):75-85. Epub 2020 Aug 20.

University of British Columbia, 212-2177 Wesbrook Mall, Vancouver, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05824-xDOI Listing
November 2020

Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis.

Invest New Drugs 2020 Oct 6;38(5):1601-1604. Epub 2020 Jan 6.

Department of Medical Oncology, BC Cancer, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-020-00892-8DOI Listing
October 2020

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

N Engl J Med 2020 02 11;382(7):597-609. Epub 2019 Dec 11.

From M.D. Anderson Cancer Center, Houston (R.K.M., G.H.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S. Loi); the Royal Marsden NHS Foundation Trust, London (A.O.), and Edinburgh Cancer Research Centre, Edinburgh (D.C.) - both in the United Kingdom; Winship Cancer Institute, Atlanta (E.P.); Sarah Cannon Research Institute/Tennessee Oncology-Nashville (E.H.) and Vanderbilt University Medical Center (V.A.), Nashville; University of California, Los Angeles, Medical Center-Jonsson Comprehensive Cancer Center, Los Angeles (S.A.H., D.S.), and Stanford Comprehensive Cancer Institute, Palo Alto (M.P.) - both in California; Dana-Farber Cancer Institute, Boston (N.U.L., I.K., E.P.W.); University of Colorado Cancer Center, Aurora (V.B.); Duke Cancer Institute, Durham (C.A.), and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill (L.A.C.) - both in North Carolina; University Health Network, Princess Margaret Cancer Centre, Toronto (P.L.B.), and British Columbia Cancer, Vancouver (K.G.) - both in Canada; Hospital Universitario Vall D'Hebron, Barcelona (M.O.); Sygehus Lillebaelt-Vejle Sygehus, Vejle, Denmark (E.J.); Centre Léon Bérard, Lyon, France (T.B.); Rambam Health Care Campus, Haifa, Israel (S.S.S.); Universitaetsklinikum Hamburg-Eppendorf, Hamburg (V.M.), and German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany; Hospital Cuf Descobertas R. Mário Botas, Lisbon, Portugal (S.B.); Cliniques Universitaires Saint-Luc, Brussels (F.P.D.); Third Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, and Cancer Cluster Salzburg, Salzburg, Austria (R.G.); Istituto Europeo di Oncologia, IRCCS, University of Milan, Milan (G.C.); and Seattle Genetics, Bothell, WA (M.C.P.-W., L.W., W.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1914609DOI Listing
February 2020

Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.

Clin Breast Cancer 2019 12 27;19(6):411-422. Epub 2019 Jun 27.

Rehabilitation Sciences, University of British Columbia, Vancouver, Canada; Department of Physical Therapy, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.05.013DOI Listing
December 2019

"Chemotherapy-periodized" Exercise to Accommodate for Cyclical Variation in Fatigue.

Med Sci Sports Exerc 2020 02;52(2):278-286

Rehabilitation Sciences Program, University of British Columbia, Vancouver, CANADA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000002151DOI Listing
February 2020

Olaparib tablets for the treatment of germ line BRCA-mutated metastatic breast cancer.

Expert Rev Clin Pharmacol 2018 Sep 30;11(9):833-839. Epub 2018 Aug 30.

a Department of Medical Oncology , BC Cancer, Vancouver Centre , Vancouver , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1513321DOI Listing
September 2018

Can We Hang Our Hats on One Percent?

Oncologist 2018 06 4;23(6):642-644. Epub 2018 May 4.

Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/23/6/642.full
Web Search
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067937PMC
June 2018

Predictors of attendance to an oncologist-referred exercise program for women with breast cancer.

Support Care Cancer 2018 Sep 13;26(9):3297-3306. Epub 2018 Apr 13.

Rehabilitation Sciences, University of British Columbia, 212-2177 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4180-7DOI Listing
September 2018

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.

Invest New Drugs 2018 12 10;36(6):1026-1036. Epub 2018 Apr 10.

Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, 305 Grattan St, Melbourne, VIC, 3000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0597-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523345PMC
December 2018

Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians' practices around seeking biopsy at the time of breast cancer relapse.

Breast Cancer Res Treat 2018 Feb 27;168(1):221-228. Epub 2017 Nov 27.

Department of Medicine, British Columbia Cancer Agency, Vancouver Cancer Centre, University of British Columbia, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4586-9DOI Listing
February 2018

The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT.

Breast Cancer Res Treat 2018 02 6;167(3):719-729. Epub 2017 Nov 6.

Department of Physical Therapy, University of British Columbia, 212-2177 Wesbrook Mall, Vancouver, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4554-4DOI Listing
February 2018

Exercise Prescription and Adherence for Breast Cancer: One Size Does Not FITT All.

Med Sci Sports Exerc 2018 02;50(2):177-186

Department of Rehabilitation Sciences, University of British Columbia, Vancouver, BC, CANADA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000001446DOI Listing
February 2018

Use of Neoadjuvant Platinum-The Ongoing Conundrum.

JAMA Oncol 2017 10;3(10):1312-1314

Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.1954DOI Listing
October 2017

Getting under the skin.

Eur J Cancer 2017 09 4;82:228-229. Epub 2017 Jun 4.

BC Cancer Agency, Medical Oncology, 600 West 10th Avenue, Vancouver, BC, V5Z4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.028DOI Listing
September 2017

Optimal Management of Early and Advanced HER2 Breast Cancer.

Am Soc Clin Oncol Educ Book 2017 ;37:76-92

From the David Geffen School of Medicine, University of California, Los Angeles, CA; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175630DOI Listing
December 2017

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Mol Genet Genomic Med 2017 May 12;5(3):251-260. Epub 2017 Mar 12.

Canadian Centre for Applied Research in Cancer Control (ARCC)Cancer Control ResearchBC Cancer AgencyVancouverBritish ColumbiaCanada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418PMC
May 2017

Palbociclib and Letrozole in Advanced Breast Cancer.

N Engl J Med 2016 11;375(20):1925-1936

From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California; Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.); U.S. Oncology Research, The Woodlands, TX (S.J.); Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); British Columbia Cancer Agency, Vancouver, Canada (K.G.); Brustzentrum der Universität München (LMU), Munich, Germany (N.H.); State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.); All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.); M.D. Anderson Cancer Center, University of Texas, Houston (S.M.); and Institut Curie, Paris (V.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607303DOI Listing
November 2016

Final Survival Analysis of ROSE/TRIO-012.

J Clin Oncol 2016 Oct;34(30):3714-3715

Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.9182DOI Listing
October 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N Engl J Med 2016 Jul 5;375(3):209-19. Epub 2016 Jun 5.

From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1604700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024713PMC
July 2016

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.

J Clin Oncol 2016 05 16;34(14):1689-701. Epub 2016 Feb 16.

Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9573DOI Listing
May 2016

Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia.

Clin Breast Cancer 2016 Jun 25;16(3):e49-55. Epub 2015 Sep 25.

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.09.005DOI Listing
June 2016

Regional Nodal Irradiation in Early-Stage Breast Cancer.

N Engl J Med 2015 Jul;373(4):307-16

From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1415340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556358PMC
July 2015

Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgery.

Gynecol Oncol Rep 2015 Apr 28;12:72-4. Epub 2015 Mar 28.

Vancouver General Hospital, BC, Canada ; University of British Columbia, Pathology and Laboratory Medicine, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2015.03.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442663PMC
April 2015

Interval versus continuous aerobic exercise training in breast cancer survivors--a pilot RCT.

Support Care Cancer 2016 Jan 9;24(1):119-127. Epub 2015 May 9.

School of Kinesiology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-015-2749-yDOI Listing
January 2016

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

J Clin Oncol 2015 May 16;33(14):1574-83. Epub 2015 Mar 16.

Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research Institute, Ottawa; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario; Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada; Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia; Bella Kaufman, Sheba Medical Centre, Tel Hashomer; Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel; Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg; Sergei Tjulandin, Russian Cancer Research Center, Moscow; Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia; Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy; Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain; Lee S. Schwartzberg, West Clinic, Memphis, TN; Arnd Nusch, Praxis, Velbert, Germany; Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom; Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan; Anne P. Connor, GlaxoSmithKline, Collegeville, PA; and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/14/1574.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.9590
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.9590DOI Listing
May 2015

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.

J Natl Cancer Inst 2015 Mar 4;107(3). Epub 2015 Mar 4.

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG); NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC); NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG); Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL); Columbia University Medical Center, New York, NY (DLH); National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR); Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM); Mayo Clinic College of Medicine, Rochester, MN (TJH); Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL); National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT); Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP); Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM); Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC); British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO); University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST); British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB); Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565534PMC
March 2015

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

Nature 2015 Feb 26;518(7539):422-6. Epub 2014 Nov 26.

1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864027PMC
February 2015

The long and winding road.

J Clin Oncol 2015 Jan 1;33(3):229-31. Epub 2014 Dec 1.

BC Cancer Agency, Vancouver, BC, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2311DOI Listing
January 2015

Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.

J Clin Oncol 2015 Jan 24;33(1):65-73. Epub 2014 Nov 24.

All authors: Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.2461DOI Listing
January 2015

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

Breast Cancer Res Treat 2014 Oct 11;147(3):617-29. Epub 2014 Sep 11.

BC Cancer Agency, Vancouver Cancer Centre, University of British Columbia, 600 W 10th Avenue, Vancouver, BC, V5Z 4E6, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3125-1DOI Listing
October 2014

Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.

J Med Screen 2014 Dec 3;21(4):180-8. Epub 2014 Sep 3.

Canadian Centre for Applied Research in Cancer Control, Vancouver, Canada Cancer Control Research, BC Cancer Agency, Vancouver, Canada School of Population and Public Health, University of British Columbia, Vancouver, Canada

View Article

Download full-text PDF

Source
http://msc.sagepub.com/content/21/4/180.full.pdf
Web Search
http://msc.sagepub.com/lookup/doi/10.1177/0969141314549758
Publisher Site
http://dx.doi.org/10.1177/0969141314549758DOI Listing
December 2014

Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.

J Clin Oncol 2015 Jan 2;33(2):141-8. Epub 2014 Sep 2.

John R. Mackey, Cross Cancer Institute; Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton; Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia; Sunil Verma, Sunnybrook Health Sciences Center; Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada; Manuel Ramos-Vazquez, Centro Oncológico de Galicia "José Antonio Quiroga y Piñeiro," A Coruña; Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, Spain; Oleg Lipatov, Republican Clinical Oncology Dispensary, Bashkortostan Republic Ministry of Health, Ufa; Dmitriy Krasnozhon, Leningrad Regional Oncology Dispensary, Leningrad; Vladimir Semiglazov, Institute of Oncology N.N. Petrov; Alexey Manikhas, City Clinical Oncology Dispensary, St Petersburg; Vera Gorbunova, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia; Nicole McCarthy, ICON Cancer Care Wesley, Brisbane, Queensland, Australia; Gottfried E. Konecny, University of California Los Angeles, Los Angeles, CA; Roberto Hegg, Hospital Pérola Byigton Centro de Referência da Saúde da Mulher, Sao Paulo, Brazil; Dany Abi Gerges, Middle East Institute of Health, Bsalim, Lebanon; Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium; and Ayman Ibrahim, ImClone Systems, Bridgewater, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.1513DOI Listing
January 2015

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

J Clin Oncol 2014 Jul 27;32(21):2255-69. Epub 2014 May 27.

Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester; Alexander J. Solky, Interlakes Onc and Hem PC, Rochester; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas A. Buchholz, Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston; Diana Rowden, Dallas, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Vered Stearns, Johns Hopkins School of Medicine, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.2258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876310PMC
July 2014

Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.

Clin Cancer Res 2014 Jun 10;20(12):3159-73. Epub 2014 Apr 10.

Authors' Affiliations: The Genome Sciences Centre; Department of Experimental Therapeutics; Medical Oncology, BC Cancer Agency; Interdisciplinary Oncology Program, Departments of Medicine and Pathology and Laboratory Medicine, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver; and Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, CanadaAuthors' Affiliations: The Genome Sciences Centre; Department of Experimental Therapeutics; Medical Oncology, BC Cancer Agency; Interdisciplinary Oncology Program, Departments of Medicine and Pathology and Laboratory Medicine, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver; and Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, CanadaAuthors' Affiliations: The Genome Sciences Centre; Department of Experimental Therapeutics; Medical Oncology, BC Cancer Agency; Interdisciplinary Oncology Program, Departments of Medicine and Pathology and Laboratory Medicine, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver; and Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2060DOI Listing
June 2014

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.

J Clin Oncol 2014 May 7;32(14):1427-36. Epub 2014 Apr 7.

Elizabeth Maunsell, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, (Axe Oncologie), Québec; Pierre Dubé, Hôpital Maisonneuve-Rosemont, Montreal, QC; Andrew L. Cooke, CancerCare Manitoba, Winnipeg, MB; Silvana Spadafora, Algoma District Cancer Program, Sault Ste. Marie, ON; Lavina Lickley, Women's College Hospital; Angela M. Cheung, University Health Network, University of Toronto, Toronto; Dianne Johnston, Andrea Hiltz, Michael Brundage, Dongsheng Tu, and Harriet Richardson, National Cancer Institute of Canada Clinical Trials Group; Joseph Pater, Queens University, Kingston, ON; Susan L. Ellard, British Columbia Cancer Agency-Southern Interior, Kelowna; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, BC, Canada; Paul E. Goss, Massachusetts General Hospital, Boston, MA; Rowan T. Chlebowski, University of California at Los Angeles Medical Centre, Torrance, CA; James N. Ingle and Sandhya Pruthi, Mayo Clinic, Rochester, MN; José E. Alés Martínez, Hospital N. S. Sonsoles, Ávila; Amparao Ruiz, Instituto Valenciano de Oncologia, Valencia, Spain; Gloria E. Sarto, Center for Women's Health & Health Research, University of Wisconsin, Madison, WI; Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Pascal Pujol, CHU-Hôpital Arnaud de Villeneuve, Montpellier, France; Susan Hendrix, Hutzel Women's Health Specialists, Detroit, MI; Debra W. Thayer, MedStar Health Research Institute, Hyattsville, MD; Kendrith M. Rowland, Carle Cancer Centre/Mills Breast Cancer Institute, Urbana, IL; and Jean Wactawski-Wende, State University of New York at Buffalo, Buffalo, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/04/03/JCO.2013.51
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.2483
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879707PMC
May 2014

Effects of exercise during adjuvant chemotherapy on breast cancer outcomes.

Med Sci Sports Exerc 2014 Sep;46(9):1744-51

1Faculty of Physical Education, University of Alberta, Edmonton, Alberta, CANADA; 2Ottawa Hospital Regional Cancer Center, Ottawa, Ontario, CANADA; 3School of Kinesiology, University of British Columbia, Vancouver, British Columbia, CANADA; 4British Columbia Cancer Agency, Vancouver, British Columbia, CANADA; 5Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, CANADA; 6University of Ottawa Heart Institute, Ottawa, Ontario, CANADA; and 7Cross Cancer Institute, Edmonton, Alberta, CANADA.

View Article

Download full-text PDF

Source
http://www.ibcpc.com/medicalpublications/documents/Outcomes.
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1249/MSS.0000000000000297DOI Listing
September 2014

A multicenter randomized trial of the effects of exercise dose and type on psychosocial distress in breast cancer patients undergoing chemotherapy.

Cancer Epidemiol Biomarkers Prev 2014 May 5;23(5):857-64. Epub 2014 Mar 5.

Authors' Affiliations: University of Alberta; Cross Cancer Institute, Edmonton; Alberta Health Services, Calgary, Alberta; University of British Columbia; British Columbia Cancer Agency, Vancouver, British Columbia; University of Ottawa Heart Institute; The Ottawa Hospital Cancer Center; and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1163DOI Listing
May 2014

Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial.

Breast Cancer Res Treat 2014 Apr 20;144(2):361-9. Epub 2014 Feb 20.

Faculty of Physical Education and Recreation, University of Alberta, E-488 Van Vliet Center, Edmonton, AB, T6G 2H9, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2883-0DOI Listing
April 2014

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.

Health Qual Life Outcomes 2013 Dec 1;11:203. Epub 2013 Dec 1.

Canadian Centre for Applied Research in Cancer Control, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7525-11-203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220776PMC
December 2013

HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.

Oncologist 2013 8;18(11):1153-66. Epub 2013 Nov 8.

Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825298PMC
October 2014

Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial.

J Natl Cancer Inst 2013 Dec 22;105(23):1821-32. Epub 2013 Oct 22.

Affiliations of authors: Faculty of Physical Education and Recreation (KSC, DC, CCF, LT), Department of Oncology (JRM), School of Public Health (YY), University of Alberta, Edmonton, Canada; School of Kinesiology (DCM, DJ, LBD), Department of Oncology (KG), University of British Columbia, Vancouver, Canada; Division of Medical Oncology, Cross Cancer Institute (JRM), Edmonton, Canada; Division of Medical Oncology, British Columbia Cancer Agency (KG), Vancouver, Canada; Department of Population Health Research, Alberta Health Services (CMF), Calgary, Canada; University of Ottawa Heart Institute (RRD), Ottawa, Canada; Ottawa Hospital Cancer Center (CP, EW, RJS), Ottawa, Canada; Ottawa Hospital Research Institute, Ottawa, Canada (EW, RJS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt297DOI Listing
December 2013

Communication challenges for chronic metastatic cancer in an era of novel therapeutics.

Qual Health Res 2013 Jul 8;23(7):863-75. Epub 2013 Apr 8.

University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1049732313483926DOI Listing
July 2013